Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3yl]-benzoic acid

Details for Australian Patent Application No. 2007300542 (hide)

Owner PTC Therapeutics, Inc.

Inventors Almstead, Neil G.; Moon, Young-Choon; Hwang, Peter Seongwoo

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007300542

PCT Pub. Number WO2008/039431

Priority 60/847,326 25.09.06 US

Filing date 24 September 2007

Wipo publication date 3 April 2008

Acceptance publication date 17 May 2012

International Classifications

C07D 271/06 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/039431 Priority application(s): WO2008/039431

17 May 2012 Application Accepted

  Published as AU-B-2007300542

13 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007300543-Compositions and methods for enhancing an adjuvant

2007300533-Apparatus, method and computer program product for synthesizing arbitrary waveforms using convolution processors